 WEST CHESTER, Pa., Aug. 10, 2021 GLOBE NEWSWIRE -- Verrica Pharmaceuticals Inc. Verrica Nasdaq: VRCA, a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced financial results for the second quarter ended June 30, 2021. 